Mesenchymal Stromal Cell-Derived Extracellular Vesicles as a Therapeutic Treatment for Osteosarcopenia: Crosstalk Among Neurons, Muscle, and Bone
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26167875 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Martina Gatti und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, 41124 Modena, Italy. Hauptthemen laut MEDLINE: Extracellular Vesicles, Mesenchymal Stem Cells, Sarcopenia, Bone and Bones. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research of the University—Fondazione di Modena.
Abstract (Originalsprache)
Osteosarcopenia is a widespread geriatric condition resulting from the coexistence of osteoporosis and sarcopenia, where the connection between bone and muscle is, in part, driven by bone–muscle crosstalk. Given the close, reciprocal influence of muscle on nerve, and vice versa, it is not surprising that there are corresponding aging changes in the biochemistry and morphology of the neuromuscular junction (NMJ). Indeed, degeneration of motor neurons and progressive disruption of the neuromuscular connectivity were observed in old age. Extracellular vesicles (EVs) derived from human amniotic fluid stem cells (hAFSC), exhibiting antioxidant properties, which can also explain their anti-aging and cytoprotective effects, can be considered as potential treatment for age-related diseases. To study cell interactions under both healthy and pathological conditions occurring in musculo–skeletal apparatus, we developed a three-culture system exploiting the use of well-known transwell supports. This system allows both myotubes and neurons, eventually treated with EVs, and osteoblasts, induced to osteoporosis, to interact physically and biochemically. Collectively, this method allowed us to understand how the modifications induced in osteoblasts during bone disorders trigger a cascade of detrimental effects in the muscle and neuron parts. Moreover, we demonstrated the efficacy of hAFSC-EVs in preventing NMJ dysfunction, muscle atrophy, and osteoblast impairment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, 41124 Modena, Italy.
- Cellular Signalling Laboratory, Department of Biomedical and Neuromotor Science, University of Bologna, 40126 Bologna, Italy.
- Department of Medical and Surgical Sciences for Mothers, Children and Adults, University of Modena and Reggio Emilia, 41124 Modena, Italy.
ORCID-Profile: Francesca Beretti, Marta Malenchini, Emma Bertucci, Eleonora Ceneri
Förderung
- Research of the University—Fondazione di Modena
Zitieren
APA
Gatti, M., Beretti, F., Malenchini, M., Bertucci, E., Ceneri, E., Follo, M. Y., & Maraldi, T. (2025). Mesenchymal Stromal Cell-Derived Extracellular Vesicles as a Therapeutic Treatment for Osteosarcopenia: Crosstalk Among Neurons, Muscle, and Bone. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26167875
Vancouver
Gatti M, Beretti F, Malenchini M, Bertucci E, Ceneri E, Follo MY, et al. Mesenchymal Stromal Cell-Derived Extracellular Vesicles as a Therapeutic Treatment for Osteosarcopenia: Crosstalk Among Neurons, Muscle, and Bone. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26167875
BibTeX
@article{Gatti2025,
author = {Gatti, Martina and Beretti, Francesca and Malenchini, Marta and Bertucci, Emma and Ceneri, Eleonora and Follo, Matilde Y and Maraldi, Tullia},
title = {Mesenchymal Stromal Cell-Derived Extracellular Vesicles as a Therapeutic Treatment for Osteosarcopenia: Crosstalk Among Neurons, Muscle, and Bone},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26167875}
}
EUVIMED